Water-Soluble Ultra-Small Manganese Oxide Surface Doped Gadolinium Oxide (Gd2O3@MnO) Nanoparticles for MRI Contrast Agent

We have developed ultra‐small gadolinium oxide (Gd2O3) nanoparticles, which are surface‐doped with manganese oxide (MnO) (abbreviated as Gd2O3@MnO). The surface‐doped nanoparticles ranged from 1 to 2 nm in diameter. They were further coated with hydrophilic biocompatible lactobionic acid. In‐vitro t...

Full description

Saved in:
Bibliographic Details
Published in:European Journal of Inorganic Chemistry 2010-10, Vol.2010 (28), p.4555-4560
Main Authors: Sook Choi, Eun, Young Park, Ja, Ju Baek, Myung, Xu, Wenlong, Kattel, Krishna, Hyun Kim, Joo, Jun Lee, Jae, Chang, Yongmin, Jeong Kim, Tae, Eun Bae, Ji, Seok Chae, Kwon, Jin Suh, Kyung, Ho Lee, Gang
Format: Article
Language:English
Subjects:
Colloids
Imaging agents
Nanoparticles
Nanotechnology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We have developed ultra‐small gadolinium oxide (Gd2O3) nanoparticles, which are surface‐doped with manganese oxide (MnO) (abbreviated as Gd2O3@MnO). The surface‐doped nanoparticles ranged from 1 to 2 nm in diameter. They were further coated with hydrophilic biocompatible lactobionic acid. In‐vitro tests of the sample solution indicated clear dose‐dependent contrast enhancements in both T1 and T2 map images, showing that the nanoparticles may be used as both T1 and T2 MRI contrast agents. Their performance as a T1 MRI contrast agent was proved in vivo through T1 MR images of a mouse. Aqueous solutions of lactobionic acid coated ultra‐small Gd2O3@MnO nanoparticles (d = 1–2 nm) may be used as both T1 and T2 MRI contrast agents because of their high relaxivities. Its capability as a T1 MRI contrast agent was proved in vivo.
ISSN:1434-1948
1099-0682
DOI:10.1002/ejic.201000374